Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVEL Trial
NCT02454348Phase 4Withdrawn
- Sponsor
- University of Arkansas
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in septic shock, sponsored by University of Arkansas. Planned start Nov 2015; status: withdrawn.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02454348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454348.